Skip to content

Investigator

Robert Harper

ANALYTICAL DIAGNOSTIC SOLUTIONS, INC. · funded by NCATS, NICHD

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$1.2M

Summed across those awards.

First award
Sep 20, 2023

Latest Jul 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now

    $305k

    Jul 1, 2025NCATSANALYTICAL DIAGNOSTIC SOLUTIONS, INC.NIH RePORTER · 11068896 (opens the source filing in a new tab)

  2. R44

    A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now

    $906k

    Sep 20, 2023NICHDANALYTICAL DIAGNOSTIC SOLUTIONS, INC.NIH RePORTER · 11253099 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources